CompletedPhase 1NCT03383523
Relative Bioavailability Study of Emodepside IR-tablets and Solution
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Drugs for Neglected Diseases
- Principal Investigator
- Jeremy DennisonHammersmith Medicines Research
- Intervention
- Emodepside (BAY 44-4400)(drug)
- Enrollment
- 77 enrolled
- Eligibility
- 18-45 years · MALE
- Timeline
- 2017 – 2018
Study locations (1)
- Hammersmith Medicines Research (HMR) Limited, London, United Kingdom
Collaborators
Bayer · Bill and Melinda Gates Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03383523 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.